Navigation Links
Patients -- Not ERs and Big Pharma -- Need Protection
Date:4/14/2011

RALEIGH, N.C., April 14, 2011 /PRNewswire/ -- Immunity shields for ERs that commit malpractice and pharmaceutical companies that sell bad drugs are unnecessary and dangerous.  Yet both are centerpieces of legislation under consideration by the House Special Committee on Tort Reform, which meets again on Thursday at 11am.  

Today, the North Carolina Coalition for Patient Safety (NC-CPS) released a new report -- based on NC court files -- showing that there were only five verdicts in NC against providers of ER care from 1999 through 2010, and only one since 2004. The highest verdict against a doctor or hospital based on substandard ER care was $650,000.

There are 4,000,000 ER visits per year in North Carolina. That means there has been about one verdict per 8,000,000 ER visits since 1999.

On Thursday, the House Select Committee on Tort Reform will vote on Senate Bill 33.  The bill includes a provision making negligence in the ER legal: an ER doctor could only be found liable if he intentionally harmed the patient.

Lobbyists for the North Carolina Medical Society have argued that providers of ER care need special legislative protection from liability.  The facts, however, do not support their argument.

Laurie Sanders, Executive Director of NC-CPS commented on the new report: "Under the current legal standard, providers of ER care have a tiny risk of being found liable for malpractice.  At the same time, 4,000 patients die and 5,700 are permanently injured in North Carolina hospitals every year because of preventable medical mistakes.  We need to give more protection to patients, not to the negligent hospitals and doctors who harm them."

Letter from Grieving Father

The committee will also vote Thursday on granting immunity to negligent drug manufacturers.  In a letter to Committee Chair Johnathan Ryhne, Andy Ayers of Eden, NC describes the death of his wife Tamara at age 22 because of a drug called Parlodel.  Tamara died just eight days after giving birth.

"My son never had the chance to be rocked to sleep or kissed goodnight by his mother," Ayers writes. "Please do not grant immunity to drug companies for their wrongdoing to North Carolinians."

Under the bill, drug companies could not be sued by those harmed by defective and dangerous drugs unless the company obtained FDA approval by fraud or bribery.  Even if the product is later found to be harmful or deadly, the drug manufacturer -- so long as it had FDA approval -- cannot be held liable.  Only one other state, Michigan, has passed a similarly extreme law, and it was the subject of a repeal movement this year.

For more information, please contact Todd@ncaj.com. Follow our news on Facebook http://www.facebook.com/pages/NC-Law-and-Politics/191212774245068 and on our website www.LetJuriesDecide.com.


'/>"/>
SOURCE NC Advocates for Justice
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. GE Healthcare Presents Interim Data on the Impact of DaTscan™ (Ioflupane I 123 Injection) SPECT Imaging on the Diagnosis and Clinical Management of Patients with Clinically Uncertain Parkinsonian Syndrome
2. Point-of-Sale Electronic Safety Check May Reduce Heart Attack Risk for Diabetic Patients
3. Qualcomm Announces Self Quality Care Project to Benefit Chronic Disease Patients in Korea
4. Texas Independent Drugstore Lobby (Continues) Putting Profits Ahead of Patients
5. Leading Rehab Facility Urges Patients Not to Stop Taking Antidepressants After New Study Suggests Increased Risk of Heart Attacks and Strokes
6. Harnessing Patients Good Intentions Can Cut 33% of Americas Pharmacy-Related Waste
7. Optimer Announces that the U.S. Food and Drug Administrations Anti-Infective Drugs Advisory Committee Voted Unanimously to Recommend Approval of Novel Antibiotic Dificid™ for Treatment of Patients with Clostridium difficile infection (CDI)
8. Jennerex and Transgene Announce the Presentation of Positive Clinical Data of JX-594 in Patients With Liver Tumors
9. Data From Landmark Clinical Trial of Abbotts MitraClip® System Demonstrate Durable Clinical Benefits for Patients With Mitral Regurgitation Two Years After Treatment
10. New Subanalyses of the RE-LY Trial Showed Pradaxa Reduced Stroke Risk in Patients With Varying CHA2DS2-VASc Scores and Types of Non-Valvular Atrial Fibrillation
11. Weight Loss With QNEXA® Over Two Years Provides Patients With Substantial Cardiovascular Benefits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... 2017 Halo Labs announces the European launch of their ... HORIZON at MIBio 2017 in Cambridge, U.K ... matter in biopharmaceutical samples with unprecedented speed and sensitivity while using ... Backgrounded Membrane Imaging. ... subvisible particle analysis system ...
(Date:9/28/2017)... Sept. 28, 2017 Cohen Veterans Bioscience and ... use of wearable and home sensors for real-time monitoring ... Signal Foundation, a nonprofit organization focused on disruptive health ... an affordable analytical system to record and integrate behavioral, ... ...
(Date:9/25/2017)... AMSTERDAM , Sept. 25, 2017   ... Trial Master File solutions, today—from the IQPC Trial ... Amsterdam , NL)—announced that EastHORN Clinical Services ... its clinical programs and TMF management. EastHORN, a ... Montrium,s eTMF platform to increase transparency to enable ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has ... least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a ... centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... and Agile Software Development, has been awarded a contract by the Center for ... Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in a ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “America On ... Christian identity. “America On The Brink” is the creation of published author, William ... several great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... treating sleep apnea using cutting-edge Oventus O2Vent technology. As many as ... disorder characterized by frequent cessation in breathing. Oral appliances can offer significant relief ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
Breaking Medicine News(10 mins):